Here are three things to know:
1. Developed by Moximed, the Calypso Knee System is designed to treat osteoarthritis in the inner knee by providing support outside of the knee joint. The implant does not alter the patient’s anatomy or remove any tissue.
2. “[The implant] works like a shock absorber to take pressure off the inside of the knee while creating a cushion similar to what cartilage provides in a healthy joint,” said David Flanigan, MD, the orthopedic surgeon who performed the surgery.
3. The surgery was part of a clinical trial to determine whether the Calypso Knee System can help prevent or delay knee replacements for osteoarthritis patients by extending the life of the joint.
More articles on devices and implants:
WishBone Medical responds to OrthoPediatrics’ trade secret allegations
Stryker organic sales growth increases for 6 years, hits 6.4% by 2018 Q3
OrthoPediatrics files sanction request against former employee, WishBone Medical in trade secret lawsuit
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
